Connexion Capital LLP
Addresses
The contact details this firm has registered with the FCA.
-
Principal Place of Business
Unit 13, 2nd Floor, Olympia HouseArmitage RoadLondonNW11 8RQUNITED KINGDOM- Phone
- +4402075895400
-
Complaints Contact
Unit 13, 2nd Floor, Olympia HouseArmitage RoadLondonNW11 8RQUNITED KINGDOM- Phone
- +4402075895400
What this firm is allowed to do
The regulated activities the FCA has granted this firm permission to carry out.
-
P2P Lending Advice
For Eligible Counterparty, Professional
-
Investment Advice (no pensions)
For Eligible Counterparty, Professional, Certificates representing certain security, Debenture, Government and public security, Rights to or interests in investments (Security), Share, Unit, Warrant
Show 1 limitation Hide limitations
- · Investment activity in "rights to or interests in investments (security)" is limited to the investment types granted for this activity.
-
Authorised to Operate
Show 1 limitation Hide limitations
- · The firm can only agree to carry on the regulated activities specified in this Notice.
-
Arranges Investments
For Eligible Counterparty, Professional, Certificates representing certain security, Debenture, Government and public security, Rights to or interests in investments (Security), Share, Unit, Warrant
Show 1 limitation Hide limitations
- · Investment activity in "rights to or interests in investments (security)" is limited to the investment types granted for this activity.
-
Investment Setup
For Eligible Counterparty, Professional, Certificates representing certain security, Debenture, Government and public security, Rights to or interests in investments (Security), Share, Unit, Warrant
Show 1 limitation Hide limitations
- · Investment activity in "rights to or interests in investments (security)" is limited to the investment types granted for this activity.
Approved individuals
Senior staff personally approved by the FCA to hold their roles here.
-
Aanand Venkatramanan
IRN AXV01272
- CF1 Director (AR) (13 Jun 2013 to 14 Apr 2014)
-
Adrian Lewis
IRN AJL01098
- CF30 Customer (7 May 2021 to 6 Dec 2022)
-
Ahmet Iplikci
IRN AXI01041
- CF1 Director (AR) (since 9 Oct 2025)
- CF30 Customer (since 9 Oct 2025)
-
Amir Ali Farman-Farmaian
IRN AAF01012
- SMF17 Money Laundering Reporting Officer (MLRO) (since 9 Dec 2019)
- SMF16 Compliance Oversight (since 9 Dec 2019)
- SMF27 Partner (since 9 Dec 2019)
- CF11 Money Laundering Reporting (9 Apr 2008 to 8 Dec 2019)
- CF8 Apportionment and Oversight (9 Apr 2008 to 31 Mar 2009)
- CF10 Compliance Oversight (9 Apr 2008 to 8 Dec 2019)
- CF4 Partner (9 Apr 2008 to 8 Dec 2019)
- CF30 Customer (9 Apr 2008 to 8 Dec 2019)
-
Angela Enzo
IRN AXE00179
- CF30 Customer (10 Nov 2023 to 12 Mar 2025)
-
Anthony Derek Woodward
IRN AXW01385
- CF4 Partner (AR) (23 Nov 2010 to 27 Dec 2012)
- CF30 Customer (23 Nov 2010 to 27 Dec 2012)
-
Anup Gopal Agrawal
IRN AGA01045
- CF1 Director (AR) (since 13 Jun 2024)
- CF30 Customer (since 13 Jun 2024)
-
Ayon Mukhopadhyay
IRN AXM02917
- CF30 Customer (since 7 Jun 2024)
-
Cenk Utkan
IRN CXU01010
- SMF27 Partner (9 Dec 2019 to 17 May 2021)
- CF30 Customer (9 Apr 2008 to 8 Dec 2019)
- CF4 Partner (9 Apr 2008 to 8 Dec 2019)
-
Christian Bernard Guy Simond
IRN CBS01011
- CF4 Partner (AR) (since 15 Apr 2025)
- CF30 Customer (since 17 Jan 2020)
Appointed representatives
Smaller firms operating under this firm's FCA authorisation.
-
DV Founders Ltd
FRN 1013355 · Appointed 14 Jun 2024
-
Accelve Limited
FRN 739567 · Appointed 13 Jun 2024
-
Cube Private Placement Ltd
FRN 995807 · Appointed 3 May 2023
-
Diversifying Strategies Limited
FRN 942886 · Appointed 30 Jan 2023
-
Ascender Fund Partners (UK) Limited
FRN 924419 · Appointed 14 Apr 2021
-
IIFL CAPITAL
FRN 937877 · Appointed 5 Nov 2020
-
MONVISO CAPITAL LTD
FRN 937371 · Appointed 29 Oct 2020
-
VIPAKA CAPITAL LIMITED
FRN 934376 · Appointed 17 Sep 2020
-
Chenevert Capital LLP
FRN 746020 · Appointed 1 Dec 2019
-
FARVIEW INTERNATIONAL LIMITED
FRN 841650 · Appointed 9 May 2019
Recent activity
Updates to this firm's record on the FCA register.
No changes recorded yet.